Loading clinical trials...
Loading clinical trials...
Addition of Buprenorphine to Paracervical Block Prior to Osmotic Dilator Insertion for Dilation and Evacuation: A Randomized Controlled Trial
Conditions
Interventions
Buprenorphine 0.15 MG
Lidocaine 1% Injectable Solution
Locations
1
United States
University of California San Diego Health
San Diego, California, United States
Start Date
May 28, 2020
Primary Completion Date
May 4, 2021
Completion Date
May 4, 2021
Last Updated
August 1, 2023
NCT07440342
NCT07259460
NCT06569537
NCT07190625
NCT07319806
NCT07292337
Lead Sponsor
University of California, San Diego
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions